Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,338 | 14,622 | 15,506 | 25,717 | 36,922 |
| Receivables | 1,052 | 1,243 | 4,152 | 3,926 | 2,260 |
| Inventories | 4,298 | 4,829 | 3,694 | 3,175 | 3,318 |
| Other current assets | 1,555 | 992 | 1,225 | 1,161 | 837 |
| TOTAL | $21,243 | $21,686 | $24,577 | $33,979 | $43,337 |
| Non-Current Assets | |||||
| PPE Net | 1,631 | 1,583 | 1,054 | 2,174 | 1,711 |
| Investments And Advances | 0 | 0 | 0 | 85 | 250 |
| Intangibles | 12,953 | 13,337 | 13,267 | 3,922 | 4,114 |
| Other Non-Current Assets | 1,871 | 2,113 | 3,162 | 3,090 | 2,122 |
| TOTAL | $16,455 | $17,033 | $17,483 | $9,271 | $8,197 |
| Total Assets | $37,698 | $38,719 | $42,060 | $43,250 | $51,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,750 | 10,371 | 7,882 | 9,784 | 2,487 |
| Accounts payable and accrued liabilities | 6,687 | 5,546 | 6,077 | 7,411 | 5,334 |
| Other current liabilities | N/A | N/A | 947 | 418 | N/A |
| TOTAL | $8,437 | $15,917 | $14,906 | $17,613 | $7,821 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,681 | 18,041 | 23,100 | 12,903 | 21,962 |
| Other Non-Current Liabilities | 0 | 9,793 | 0 | 2,250 | 2,537 |
| TOTAL | $17,055 | $28,504 | $24,022 | $19,182 | $33,767 |
| Total Liabilities | $25,492 | $44,421 | $38,928 | $36,795 | $41,588 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 195,187 | 108,181 | 75,448 | 67,173 | 57,929 |
| Common Shares | 13 | 99 | 71 | 66 | 57 |
| Retained earnings | -357,017 | -338,273 | -300,905 | -274,728 | -242,449 |
| Other shareholders' equity | 996 | 700 | 256 | 0 | 0 |
| TOTAL | $12,206 | $-5,702 | $3,132 | $6,455 | $9,946 |
| Total Liabilities And Equity | $37,698 | $38,719 | $42,060 | $43,250 | $51,534 |